3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
2
Neoplasms
2
Malnutrition
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Thrombosis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasms
1
Radiation Injuries
1
Protein Metabolism
1
Polycystic Ovary Syndrome
1
Pain
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Meningioma
1
Hemorrhage
1
Glioblastoma
1
Erectile Dysfunction
1
Disease
1
Diabetes Insipidus
1
Brain Neoplasms
1
Interventions
Tranexamic Acid
13
Sodium Chloride
4
Misoprostol
4
Saline Solution
3
Enoxaparin
3
carbetocin
2
Tourniquets
2
Ringer's Lactate
2
Oxytocin
2
Endoscopic Mucosal Resection
2
Dalteparin
2
maleimide-polyethylene glycol-modified hemoglobin, MP4
1
bemiparin
1
Vitamin B 6
1
Vasopressins
1
Uterine Myomectomy
1
Uterine Artery Embolization
1
Tinzaparin
1
Thoracic Surgery, Video-Assisted
1
Terlipressin
1
Sutures
1
Surgicel
1
Standard of Care
1
Solutions
1
Sensitivity Training Groups
1
Rivaroxaban
1
Ringer's Solution
1
Radiotherapy
1
Proton Pump Inhibitors
1
Palliative Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hemorrhage
×
Arginine
×
Clear all
NCT05293041
2025-03-06
ARG-01
Sahlgrenska University Hospital
Phase 4
Completed
248 enrolled